Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

RESMED INC
ASX:RMD

RESMED INC

Health Care

Resmed Inc. (RMD) is a global company involved in the development, manufacturing and marketing of medical products for the treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. RMD sells a range of products in approximately 100 countries worldwide through direct offices and a network of distributors.

Read more

Market Cap

$10.05b

Price at Close

$28.01

4w avg. Volume

977.63k

4w avg. Turnover

$27.89m

Announcements
announcementt+2 movementdate
  • FORM 8-K Annual Meeting Stockholders

    Notice Of Meeting

  • -2.78%

    23 Nov 2020

-2.78%

23 Nov 2020
  • Update - Dividend/Distribution - RMD

    Dividend Announcement

  • +0.10%

    12 Nov 2020

+0.10%

12 Nov 2020
  • FORM-8K/A

    Dividend Announcement · Market sensitive

  • +0.27%

    10 Nov 2020

+0.27%

10 Nov 2020
  • Chess Depositary Interest - RMD

    Issued Capital

  • +2.42%

    04 Nov 2020

+2.42%

04 Nov 2020
  • FORM 10Q for Qtr ended September, 2020

    Periodic Reports

  • +3.71%

    01 Nov 2020

+3.71%

01 Nov 2020
  • Dividend/Distribution - RMD

    Dividend Announcement

  • +7.68%

    29 Oct 2020

+7.68%

29 Oct 2020
  • ResMed Announces Results for the First Quarter of FY2021

    Periodic Reports · Market sensitive

  • +7.68%

    29 Oct 2020

+7.68%

29 Oct 2020
  • RMD to Report First Quarter Fiscal 2021 Results

    Periodic Reports

  • +1.27%

    08 Oct 2020

+1.27%

08 Oct 2020
  • Notice of Annual General Meeting/Proxy Form

    Notice Of Meeting

  • +3.05%

    06 Oct 2020

+3.05%

06 Oct 2020
  • Notice of Annual General Meeting/Proxy Form

    Notice Of Meeting

  • +3.05%

    06 Oct 2020

+3.05%

06 Oct 2020
Market Data

Current Price

$28.01

52WK HIGH

$30.08

52WK LOW

$18.1

1YR RETURN

+28.90%

1YR RETURN VS. SECTOR

-4.52%

90 DAY RETURN

+12.13%

ASX RANK

47

/2,024

SECTOR RANK

3

/28

SHARES OUTSTANDING

358.68m
ASX:RMD

RESMED INC

Health Care

Resmed Inc. (RMD) is a global company involved in the development, manufacturing and marketing of medical products for the treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. RMD sells a range of products in approximately 100 countries worldwide through direct offices and a network of distributors.

Read more

Market Cap

$10.05b

Price at Close

$28.01

4w avg. Volume

977.63k

4w avg. Turnover

$27.89m

ASX:RMD is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.